OUR PARTNERS ARE FEATURED ON
Financial Times - global financial and business media EUSA PR
TechCrunch - US tech startup and venture capital media EUSA PR
Le Monde - French national newspaper media coverage EUSA PR
The Guardian - UK national news and technology media EUSA PR
Financieel Dagblad - Dutch financial newspaper EUSA PR
Associated Press - global newswire media coverage EUSA PR
Forbes - US business and leadership media EUSA PR
Reuters - global newswire and financial media EUSA PR
Bloomberg - global financial data and media EUSA PR
Insider - US business and tech media coverage EUSA PR
Financial Times - global financial and business media EUSA PR
TechCrunch - US tech startup and venture capital media EUSA PR
Le Monde - French national newspaper media coverage EUSA PR
The Guardian - UK national news and technology media EUSA PR
Financieel Dagblad - Dutch financial newspaper EUSA PR
Associated Press - global newswire media coverage EUSA PR
Forbes - US business and leadership media EUSA PR
Reuters - global newswire and financial media EUSA PR
Bloomberg - global financial data and media EUSA PR
Insider - US business and tech media coverage EUSA PR

Biotech PR That Builds Trust and Visibility

Biotechnology operates in one of the most complex and highly regulated industries in the world. From drug development and genomics to diagnostics and advanced therapeutics, biotech companies must communicate innovation with clarity and credibility. Strategic Biotech PR translates complex science into clear, responsible stories that build trust with media, investors, partners and the wider healthcare ecosystem. By positioning research milestones, clinical progress and leadership expertise accurately, biotech public relations strengthens reputation, increases visibility and supports sustainable growth in international markets.
Get in touch
A blue flaf with the EU stars displayed on it
A blue flaf with the EU stars displayed on it

Strategic Biotech Public Relations, Explained

Effective biotech PR goes beyond media coverage. It focuses on building long-term credibility through consistent, science-driven communication. Specialized biotech public relations supports biotechnology companies in explaining research, clinical data and regulatory progress in ways that are accurate, accessible and compliant. By aligning scientific storytelling with business objectives, biotech communications supports fundraising, partnerships and market expansion while ensuring innovation is understood, trusted and valued across the life sciences industry.
Get in touch

Let’s make headlines

Let’s make headlines

Let’s make headlines

Let’s make headlines

Your message has officially gone to press.
Oops! Something went wrong while submitting the form.

Other industries

We help innovators in the most transformative industries.
Visual of healthtech and medical technology, supported by EUSA PR for cross-border PR strategy and international media visibility

Healthtech

Healthtech PR for Digital Health and Medical Technology
Read more
Visual of deeptech and AI-driven breakthrough, supported by EUSA PR for cross-border communications and international media relations

Deeptech

Deeptech PR for Europe’s Breakthrough Innovators
Read more
Visual of cleantech and clean energy breakthrough, supported by EUSA PR for cross-border media strategy and international PR

Cleantech

Cleantech PR for Breakthrough Climate Innovation
Read more